Streamlining a TAVR Procedure From screening to post TAVR care Hatim Al Lawati

Size: px
Start display at page:

Download "Streamlining a TAVR Procedure From screening to post TAVR care Hatim Al Lawati"

Transcription

1 Streamlining a TAVR Procedure From screening to post TAVR care Hatim Al Lawati Consultant Interventional Cardiology Sultan Qaboos University Hospital Muscat Oman

2 Speaker's name: Hatim Al Lawati, SQUH - Oman I do not have any potential conflict of interest

3 TAVR LANDSCAPE: STS SCORE Severe AS, Symptomatic Low Risk <3% Int. Risk STS 3-7% High Risk STS 7-10% Extreme Risk STS >10% On-Going Clinical Trials TAVR Indicated Patient Populations 1. STS Adult Cardiac Database Harvest, Isolated AVR. 2. Bach, et al. JACC. 2007;50(20): Iung B, et al. European Heart Journal. 2003;24: Pellikka et al. Circulation. 2005;111: Charlson, et al. Journal of Heart Valve Disease. 2006;15: Nkomo, et al. Lancet. 2006;368: Lindroos, et al. JACC. 1993;21(5): Mack M, JAMA 2013;310(19): Medtronic Data On File.

4 Agenda Pillars to streamline TAVR: Proper Patients Referrals Screening Optimization TAVR procedure simplification Discharge considerations

5 Proper Patient Referrals Successful programs should employ a multifaceted approach to educate and engage community physicians, using tactics such as valve coordinator outreach, educational sessions, easy-to-use referral guidelines, and dedicated valve center referral lines. Valve centers should also set high service standards to ensure referring physicians will continue to refer. Consistent communication is critical throughout the care continuum, from screening to post-procedure follow-up, so referrers do not feel they have lost control of their patients. In addition to educating referring physicians, TAVR programs can also hardwire identification of patients who would benefit from further evaluation at the valve clinic through echo screening or echo alert protocols to identify patients with severe AS

6 TAVR Screening Optimization Consolidate the screening process as much as possible to optimize patient convenience and expedite time to treatment Develop a one-stop-shop screening approach, in which a patient receives all or nearly all screening and physician consults during one visit at the TAVR clinic, and ideally in one location Dedicate one or two TAVR screening days per week, to ensure physician and lab availability. Situate the clinic rooms in close proximity to diagnostic testing labs (e.g., echo, cath lab) to streamline the process and improve patient convenience.

7 TAVR Procedure Simplification Use of stiff LV wire for pacing instead of the temporary transvenous pacemaker wire Conscious sedation instead of general anesthesia Transthoracic instead of Transesophageal Ultrasound guided access Use of low profile sheaths/delivery systems of TAVR (14 Fr) to minimize vascular complications Use of new closure devices (like MANTA) Management of central lines and pacemaker

8 Alternative to transvenous pacing Use of stiff LV wire for pacing instead of the Temporary transvenous pacemaker wire Set up of the LV pacing system

9 Catheter Cardiovasc Interv 2016; 88: METHODS: A prospective, observational registry study was conducted in three French centers (the GHM and CHU in Grenoble and the Clinique du Tonkin in Lyon) included patients undergoing BAV or TAVR for severe aortic stenosis. The primary objective of the registry was the assessment of the efficiency of left ventricular rapid pacing during BAV or TAVR procedures. The secondary objectives were the assessment of the safety and tolerance of left ventricular rapid pacing during BAV or TAVR, as well as systematic in-hospital follow-up of the registry patients.

10 Description of the Technique Both BAV and TAVR procedures were carried out using standard techniques, but no systematic femoral vein puncture was performed for the RV lead. Rapid ventricular pacing (rate between 160 and 200 bpm) was provided via the back-up guidewire The cathode of an external pacemaker is placed on the external end of the wire using an alligator clamp. The balloon or the TAVR catheter provides the necessary insulation. The anode is placed (also using an alligator clamp) on a small needle piercing the subcutaneous tissue at the site of the anesthetized groin If a complete atrio-ventricular block (AVB) occured during the procedure, immediate stimulation was delivered through the LV guidewire while a venous sheath was inserted for temporary pacing lead placement in the right ventricle and PM implantation was carried out within the next 24 hr., if required.

11 Results 113 consecutive patients underwent 38 BAV and 87 TAVR procedures in three centers using this technique. Left ventricular pacing was successfully implemented in all patients with one for one pacing ( bpm) obtained in each case. A significant reduction in blood pressure was achieved in all cases with a mean systolic pressure during stimulation of 44 mm Hg. No venous vascular complications were observed in the study population.

12 Conscious Sedation vs. General Anesthesia Pros: - Avoids intubation: - Difficulty weaning - Possible trauma - Difficulty with swallowing - Avoids deep sedation - Frequently requires pressors - Confusion - Nausea/vomiting - Delays mobilization Cons: - Less control of patient - May have some local pain - Consider using long acting local anesthetic e.g. Bupivacaine - Without TEE - Typically avoids TEE - Intra-procedural feedback - Added benefit: quicker room turn over time **J Thorac Cardiovasc Surg Oct;150(4): doi: /j.jtcvs Epub 2015 Jul 30

13 Conscious sedation improved outcomes in high risk patients Evaluation of TVT Registry from April 2014-June ,997 patient evaluated 1,737 had conscious sedation (15.8%) Risk of 30-Day Outcomes, Moderate Sedation vs General Anesthesia* 30-day outcomes Moderate sedation (%) General Anesthesia (%) Odd ratio P Mortality <0.001 Mortality or Stroke <0.001 *Adjusted for 51 baseline variables Source: Giri J, SCAI 2016

14 Conscious Sedation: how do you start? Many questions and few answers exist in public domain Sedation Do you include anesthesia? What type of drugs are used? How deep a level of sedation should be taregtted? How do you start this within your institution? Appropriate patient selection Consensus within the Heart Team Training and Education

15 Sedation: One center approach Initially, deep sedation with Propofol You want to have a successful experience for your patient and staff OR staff are not used to having patients feel any pain, get their buy-in first Consider eventual transition to light Propofol + Dexmedetomidine (Precedex ) Identification of pain has allowed us to avoid potential vascular complications Continue to use anesthesia staffing for sedation

16 Transthoracic instead of trans-esophageal echo Questions: How to transition away from TEE? When TTE imaging is poor, how do you evaluate? Utility of TTE: Quantify PVL Evaluate for tamponade Put the probe on up front Can I get good windows? Is there a fat pad or small effusion pre-procedure? Keep in mind that aortography is a much more reliable tool than TTE and primary modality for evaluation of PVL combined with hemodynamics

17 Hemodynamics are your friend! Calculation of the AR index AR Index = (DBP-LVEDP)/SBP x 100 subjects with a AR index >25 had significantly lower mortality Sinning JACC 2012

18 Hemodynamics are your friend! Calculation of the AR index Freedom from all-cause mortality. Kaplan-Meir estimates of cumulative survival according to the degree of peri-ar as assessed by echocardiography (A) and according to the AR index (B). Sinning JACC 2012

19 Ultrasound guided vascular access

20 Ultrasound guided vascular access

21 Ultrasound guided vascular access Conclusions: In this multicenter randomized controlled trial, the US guided puncture reduced the number of attempts, time to access, risk of venipunctures, and vascular complications in femoral arterial access.

22 Ultrasound guided vascular access Common femoral artery placement success US guidance did not demonstrate a significantly superior rate of sheath placement in the common femoral artery in the overall population or the obese or peripheral vascular disease subgroups. US guidance significantly increased common femoral sheath placements in the 31% of patients who had a femoral bifurcation over the femoral head p<0.01

23 Use of low profile sheaths/delivery systems of TAVR to minimize vascular complications

24 Use of new closure devices (e.g. MANTA) It is a new device (CE approved already) and we will need time and experience to reveal if it will contribute to the simplification of the closure in TAVR and thus reduce bleeding/hematoma at the closure site.

25 Invasive lines and pacemaker management Foley catheters: In the case of Trans-femoral TAVR, no need to have a Foley catheter placed in an attempt to reduce urological issues during/after the procedure. Temporary venous pacemaker: For patients with narrow QRS with no changes during the procedure, the guidelines recommend that the temporary pacer should be removed at the end of the procedure.

26 Post-implant Care: pacer guidelines supporting evidence The Electrocardiogram After Transcatheter Aortic Valve Replacement Determines the Risk for Post-Procedural High-Degree AV Block and the Need for Telemetry Monitoring The most important finding of this study is that patients without a left- or right bundle branch block and without firstdegree AVB post-tavr did not develop high-degree AVB during the first 30 days postprocedure. Similarly, patients with atrial fibrillation but no bundle branch block and no bradycardia post-tavr had a very low risk of delayed highdegree AVB. Patients in sinus rhythm without conduction disorders post-tavr did not develop delayed high-degree AVB (0 of 250, 0%) In this study, only patients with QRS duration <120 ms and absence of first-degree AVB did not develop high-degree AVB. Toggweiler, S., et al. JACC: Interventions, 9(12),

27 Consideration for early discharge No ICU stay in transfemoral cases patient transferred from procedure room to ward Stable heart rhythm not requiring pacing within 24h Vital signs stable Effective pain control Ambulates 200 feet or at baseline Groins without bleeding/hematoma Family with appropriate understanding of discharge instructions Plan discharge before admission!

28 Conclusions Streamlining allows for faster, easier and cost effective procedure without impacting the safety and efficacy of TAVR Such methodology requires pre-, peri- and postprocedural planning favoring the trans-femoral (percutaneous) approach Plan to discharge the TAVR patient before admission

29 Streamlining a TAVR Procedure From screening to post TAVR care THANK YOU!

30

Edwards Sapien. Medtronic CoreValve. Inoperable FDA approved High risk: in trials. FDA approved

Edwards Sapien. Medtronic CoreValve. Inoperable FDA approved High risk: in trials. FDA approved Transcatheter Aortic Valve Replacement Symptomatic Aortic Stenosis Asymptomatic Juan Crestanello, MD Interim Director, Division of Cardiac Surgery Associate Professor Division of Cardiac Surgery The Ohio

More information

TAVR: Echo Measurements Pre, Post And Intra Procedure

TAVR: Echo Measurements Pre, Post And Intra Procedure 2017 ASE Florida, Orlando, FL October 10, 2017 8:00 8:25 AM 25 min TAVR: Echo Measurements Pre, Post And Intra Procedure Muhamed Sarić MD, PhD, MPA Director of Noninvasive Cardiology Echo Lab Associate

More information

Minimalist Transcatheter Aortic Valve Replacement (MA-TAVR)

Minimalist Transcatheter Aortic Valve Replacement (MA-TAVR) Minimalist Transcatheter Aortic Valve Replacement (MA-TAVR) Jensen HA, Condado JF, Devireddy C, Binongo JN, Leshnower BG, Babaliaros V, Sarin EL, Lerakis S, Guyton RA, Stewart JP, Syed AQ, Mavromatis K,

More information

Transcatheter procedures of the future; expanding the treatment options for patients with severe aortic stenosis

Transcatheter procedures of the future; expanding the treatment options for patients with severe aortic stenosis Transcatheter procedures of the future; expanding the treatment options for patients with severe aortic stenosis John Webb MD Director interventional cardiology, St Paul s Hospital McLeod Professor of

More information

The Future of TAVR: Minimalist Fast Track

The Future of TAVR: Minimalist Fast Track The Future of TAVR: Minimalist Fast Track Zvonimir Krajcer, MD Program Director- Peripheral Vascular Interventions Department of Cardiology, St. Luke s Episcopal Hospital and Texas Heart Institute, Houston,

More information

Transcatheter Aortic Valve Implantation Procedure (TAVI)

Transcatheter Aortic Valve Implantation Procedure (TAVI) Page 1 of 5 Procedure (TAVI) Introduction Aortic stenosis (AS) is a common heart valve problem associated with heart failure and death. Surgical valve repair or replacement is recommended if AS patients

More information

TAVR: Intermediate Risk Patients

TAVR: Intermediate Risk Patients TAVR: Intermediate Risk Patients Oscar A. Mendiz.MD.FACC.FSCAI Director Cardiology & Cardiovascular Institute (ICyCC) Chief Interventional Cardiology Department Board of Directors Hospital & Favaloro University

More information

Menachem M. Weiner Assistant Professor of Anesthesiology Icahn School of Medicine at Mount Sinai

Menachem M. Weiner Assistant Professor of Anesthesiology Icahn School of Medicine at Mount Sinai Menachem M. Weiner Assistant Professor of Anesthesiology Icahn School of Medicine at Mount Sinai Anesthetic care and considerations Intraoperative events TEE Perioperative complications Most common valvular

More information

Bioprosthetic Mitral Valve Dysfunction: Innovation and Evolution of a New Therapeutic Technique

Bioprosthetic Mitral Valve Dysfunction: Innovation and Evolution of a New Therapeutic Technique Bioprosthetic Mitral Valve Dysfunction: Innovation and Evolution of a New Therapeutic Technique Charanjit S. Rihal MD MBA Professor and Chair Division of Cardiovascular Diseases Mayo Clinic DISCLOSURES

More information

Transcatheter aortic valve replacement with intracardiac echocardiography from the right internal jugular vein

Transcatheter aortic valve replacement with intracardiac echocardiography from the right internal jugular vein Case Report Transcatheter aortic valve replacement with intracardiac echocardiography from the right internal jugular vein Hiroto Yagasaki 1, Yoshiaki Goto 1, Yoshio Mori 2, Toshiyuki Noda 1 1 Department

More information

Adult Cardiology Clinical Privileges

Adult Cardiology Clinical Privileges Name: Effective from / / to / / Initial privileges (initial appointment) (reappointment) Renewal of privileges All new applicants should meet the following requirements as approved by the governing body,

More information

I Was Too Late With Device Placement

I Was Too Late With Device Placement SCAI SHOCK 2018 A Team-Based Course On Cardiogenic Shock General Session # 2 Saturday, October 13, 2018 8:39 8:51 AM Boston Park Plaza - Boston, MA I Was Too Late With Device Placement M Chadi Alraies,

More information

Heart Team For TAVI Who and How?

Heart Team For TAVI Who and How? 2 nd TAVI Summit 2012, Seoul Corea Heart Team For TAVI Who and How? Alain Cribier, MD, Charles Nicolle Hospital University of Rouen, France Disclosure Edwards Lifesciences Consultant Training / proctoring

More information

CIPG Transcatheter Aortic Valve Replacement- When Is Less, More?

CIPG Transcatheter Aortic Valve Replacement- When Is Less, More? CIPG 2013 Transcatheter Aortic Valve Replacement- When Is Less, More? James D. Rossen, M.D. Professor of Medicine and Neurosurgery Director, Cardiac Catheterization Laboratory and Interventional Cardiology

More information

Left ventricular guidewire pacing for transcatheter aortic valve. implantation

Left ventricular guidewire pacing for transcatheter aortic valve. implantation Page 1 of 8 Left ventricular guidewire pacing for transcatheter aortic valve implantation Ênio E. Guérios, MD 1, 2, Peter Wenaweser, MD 1, Bernhard Meier, MD 1 1 Department of Cardiology, Bern University

More information

INTERNAL CARDIOVERSION. Lancashire & South Cumbria Cardiac Network

INTERNAL CARDIOVERSION. Lancashire & South Cumbria Cardiac Network INTERNAL CARDIOVERSION Lancashire & South Cumbria Cardiac Network DC Cardioversion AF & AFL safe 1,2 efficacious 3,4 (60-94%) 5 SR - Increases exercise tolerance 6 Maintainence SR unlikely in patients

More information

TAVI: The Real Deal? Marc Pelletier, MD Head, Department of Cardiac Surgery New Brunswick Heart Centre

TAVI: The Real Deal? Marc Pelletier, MD Head, Department of Cardiac Surgery New Brunswick Heart Centre TAVI: The Real Deal? Marc Pelletier, MD Head, Department of Cardiac Surgery New Brunswick Heart Centre Disclosure St. Jude Medical: Consultant and Proctor Edwards Lifesciences: Proctor Medtronic: Research

More information

Igor Palacios, MD Director of Interventional Cardiology Massachusetts General Hospital Professor of Medicine Harvard Medical School

Igor Palacios, MD Director of Interventional Cardiology Massachusetts General Hospital Professor of Medicine Harvard Medical School Aortic Stenosis: Current State of Percutaneous Therapies, Emerging Technologies and Future Directions Igor Palacios, MD Director of Interventional Cardiology Massachusetts General Hospital Professor of

More information

TGA atrial vs arterial switch what do we need to look for and how to react

TGA atrial vs arterial switch what do we need to look for and how to react TGA atrial vs arterial switch what do we need to look for and how to react Folkert Meijboom, MD, PhD, FES Dept ardiology University Medical entre Utrecht The Netherlands TGA + atrial switch: Follow-up

More information

Case Report Hemostasis of Left Atrial Appendage Bleed With Lariat Device

Case Report Hemostasis of Left Atrial Appendage Bleed With Lariat Device 273 Case Report Hemostasis of Left Atrial Appendage Bleed With Lariat Device Amena Hussain MD, Muhamed Saric MD, Scott Bernstein MD, Douglas Holmes MD, Larry Chinitz MD NYU Langone Medical Center, United

More information

Trend and Outcomes of Direct Transcatheter Aortic Valve Replacement from a Single-Center Experience

Trend and Outcomes of Direct Transcatheter Aortic Valve Replacement from a Single-Center Experience Cardiol Ther (2018) 7:191 196 https://doi.org/10.1007/s40119-018-0115-0 BRIEF REPORT Trend and Outcomes of Direct Transcatheter Aortic Valve Replacement from a Single-Center Experience Anthony A. Bavry.

More information

Dr. Jean-Claude Laborde

Dr. Jean-Claude Laborde Medtronic CoreValve Experience Alternative Access (Subclavian) and Technology Evolution of the Medtronic CoreValve TAVI System Dr. Jean-Claude Laborde Glenfield Hospital, Leicester, U.K. St George Hospital,

More information

Cardiac Valve/Structural Therapies

Cardiac Valve/Structural Therapies Property of Dr. Chad Rammohan Cardiac Valve/Structural Therapies Chad Rammohan, MD FACC Medical Director, El Camino Hospital Cardiac Catheterization Lab Director, Interventional and Structural Cardiology,

More information

Structural Heart Disease: Setting the Stage for Success

Structural Heart Disease: Setting the Stage for Success Structural Heart Disease: Setting the Stage for Success Brenda McCulloch, RN MSN RCIS Cardiovascular Clinical Nurse Specialist, Interventional & Medical Cardiology Sutter Medical Center, Sacramento mccullb@sutterhealth.org

More information

TAVR Cases. Disclosures 2/17/2018. February 17, :15 3:30 PM 15 min

TAVR Cases. Disclosures 2/17/2018. February 17, :15 3:30 PM 15 min 31 st Annual State of the Art Echocardiography San Diego, CA February 17, 2018 3:15 3:30 PM 15 min TAVR Cases Muhamed Sarić MD, PhD, MPA Director of Noninvasive Cardiology Echo Lab Associate Professor

More information

Catheter Based Valve Interventions. Matthew Caldwell, MD February 5, 2019 Puerto Vallarta, Mexico

Catheter Based Valve Interventions. Matthew Caldwell, MD February 5, 2019 Puerto Vallarta, Mexico Catheter Based Valve Interventions Matthew Caldwell, MD February 5, 2019 Puerto Vallarta, Mexico Relevance to Non-Cardiac Anesthesiologist Approx 12% of adults >75 years have mod-severe valve disease

More information

Is TAVR the treatment of choice for high risk diabetic patients with aortic stenosis? Insights from the FRANCE2 Registry

Is TAVR the treatment of choice for high risk diabetic patients with aortic stenosis? Insights from the FRANCE2 Registry Is TAVR the treatment of choice for high risk diabetic patients with aortic stenosis? Insights from the FRANCE2 Registry E Van Belle, E Teiger, F Juthier, A Vincentelli, B Iung, H Eltchaninoff, J Fajadet,

More information

AORTIC STENOSIS HENRY FORD HOSPITAL CENTER FOR STRUCTURAL HEART DISEASE

AORTIC STENOSIS HENRY FORD HOSPITAL CENTER FOR STRUCTURAL HEART DISEASE AORTIC STENOSIS HENRY FORD HOSPITAL CENTER FOR STRUCTURAL HEART DISEASE WHAT IS AORTIC STENOSIS? THE AORTIC VALVE The aorta is the major vessel that carries oxygenated blood out of the left side of the

More information

University of Wisconsin - Madison Cardiovascular Medicine Fellowship Program UW CCU Rotation Goals and Objectives Goals

University of Wisconsin - Madison Cardiovascular Medicine Fellowship Program UW CCU Rotation Goals and Objectives Goals Goals Learn to coordinate a variety of data from multiple cardiovascular sub-disciplines, e.g. catheterization laboratory, hemodynamic study, non-invasive imaging, nuclear, electrophysiologic, and in combination

More information

Transcatheter Aortic Valve Replacement (TAVR)

Transcatheter Aortic Valve Replacement (TAVR) UW MEDICINE PATIENT EDUCATION Transcatheter Aortic Valve Replacement (TAVR) Treatment for aortic stenosis This handout explains when your doctor may advise TAVR to treat aortic stenosis. It includes the

More information

Aortic valve implantation using the femoral and apical access: a single center experience.

Aortic valve implantation using the femoral and apical access: a single center experience. Aortic valve implantation using the femoral and apical access: a single center experience. R. Hoffmann, K. Brehmer, R. Koos, R. Autschbach, N. Marx, G. Dohmen Rainer Hoffmann, University Aachen, Germany

More information

0 P a g e NEIL E STRICKMAN MD

0 P a g e NEIL E STRICKMAN MD 0 P a g e NEIL E STRICKMAN MD T ranscatheter Aortic Valve Replacement INTRODUCTION The heart is a muscular organ located in your chest between your lungs which is designed to pump blood throughout the

More information

Implantation of Cardioverter Defibrillator After Percutaneous Closure of Atrial Septal Defect

Implantation of Cardioverter Defibrillator After Percutaneous Closure of Atrial Septal Defect The Ochsner Journal 10:27 31, 2010 f Academic Division of Ochsner Clinic Foundation Implantation of Cardioverter Defibrillator After Percutaneous Closure of Atrial Septal Defect Anas Bitar, MD, Maria Malaya

More information

Transcatheter Aortic Valve Replacement with a Self-Expanding Prosthesis or Surgical Aortic Valve Replacement in Intermediate-Risk Patients:

Transcatheter Aortic Valve Replacement with a Self-Expanding Prosthesis or Surgical Aortic Valve Replacement in Intermediate-Risk Patients: Transcatheter Aortic Valve Replacement with a Self-Expanding Prosthesis or Surgical Aortic Valve Replacement in Intermediate-Risk Patients: 1-Year Results from the SURTAVI Clinical Trial Nicolas M. Van

More information

Transcatheter Aortic Valve Implantation Anaesthetic Prespectives

Transcatheter Aortic Valve Implantation Anaesthetic Prespectives Transcatheter Aortic Valve Implantation Anaesthetic Prespectives Dr Simon Chan Consultant Department of Anaesthesia and Intensive Care Prince of Wales Hospital Hong Kong 11 Oct 2014 Aortic Stenosis Prevalence

More information

TAVR 2018: TAVR has high clinical efficacy according to baseline patient risk! ii. Con

TAVR 2018: TAVR has high clinical efficacy according to baseline patient risk! ii. Con TAVR 2018: TAVR has high clinical efficacy according to baseline patient risk! ii. Con Dimitrios C. Angouras, MD, FETCS Associate Professor of Cardiac Surgery National and Kapodistrian University of Athens,

More information

How Do I Evaluate a Patient Being Considered for TAVR? Sunday, February 14, :00 11:25 PM 25 min

How Do I Evaluate a Patient Being Considered for TAVR? Sunday, February 14, :00 11:25 PM 25 min 2016 ASE State of the Art Echocardiography Course Tucson, AZ How Do I Evaluate a Patient Being Considered for TAVR? Sunday, February 14, 2016 11:00 11:25 PM 25 min 1 M U H A M E D S A R I Ć, M D, P H D

More information

A new option for the Diagnosis and Management of Valvular Heart Disease. Oregon Comprehensive Valve Center

A new option for the Diagnosis and Management of Valvular Heart Disease. Oregon Comprehensive Valve Center A new option for the Diagnosis and Management of Valvular Heart Disease Oregon Comprehensive Valve Center I have no disclosures Oregon Comprehensive Valve Center Weekly multidisciplinary case conferences

More information

1-YEAR OUTCOMES FROM JOHN WEBB, MD

1-YEAR OUTCOMES FROM JOHN WEBB, MD 1-YEAR OUTCOMES FROM JOHN WEBB, MD ON BEHALF OF THE SAPIEN 3 INVESTIGATORS UNIVERSITY OF BRITISH COLUMBIA VANCOUVER, CANADA Potential conflicts of interest Speaker's name: John Webb I have the following

More information

*Core lab for numerous trials, for which I receive no direct compensation from sponsors.

*Core lab for numerous trials, for which I receive no direct compensation from sponsors. Rebecca T. Hahn, MD, FACC, FASE Director of Interventional Echo Professor of Medicine Columbia University Company Abbott Vascular Gore&Assoc NaviGATE Medtronic Boston Scientific GE Medical Philips Healthcare

More information

Percutaneous Therapy for Calcific Mitral Valve Disease

Percutaneous Therapy for Calcific Mitral Valve Disease 31 st Annual State of the Art Echocardiography San Diego, CA February 18, 2018 5:00 5:15 PM 15 min Percutaneous Therapy for Calcific Mitral Valve Disease Muhamed Sarić MD, PhD, MPA Director of Noninvasive

More information

TAVI in Rabin Medical Center -

TAVI in Rabin Medical Center - Long-Term Outcomes of 560 Consecutive Patients treated with TAVI and Propensity Score Matched- Analysis of Early Versus New Generation Valves Amos Levi, MD, Uri Landes, MD, Abid R Assali, MD, Katia Orvin,

More information

2/28/2010. Speakers s name: Paul Chiam. I have the following potential conflicts of interest to report: NONE. Antegrade transvenous transseptal route

2/28/2010. Speakers s name: Paul Chiam. I have the following potential conflicts of interest to report: NONE. Antegrade transvenous transseptal route Transcatheter Aortic Valve Implantation Asian perspective Speakers s name: Paul Chiam Paul TL Chiam MBBS, MRCP, FACC I have the following potential conflicts of interest to report: NONE Consultant National

More information

Shock, Monitoring Invasive Vs. Non Invasive

Shock, Monitoring Invasive Vs. Non Invasive Shock, Monitoring Invasive Vs. Non Invasive Paula Ferrada MD Assistant Professor Trauma, Critical Care and Emergency Surgery Virginia Commonwealth University Shock Fluid Pressors Ionotrope Intervention

More information

State of the Art of PEVAR

State of the Art of PEVAR State of the Art of PEVAR Zvonimir Krajcer, MD Program Director- Peripheral Vascular Interventions Department of Cardiology, St. Luke s Episcopal Hospital and Texas Heart Institute, Houston, TX Disclosures

More information

TAVR: It s a Career, Not Just a Procedure! Jeffrey A Southard, MD Cardiology May 5, 2012

TAVR: It s a Career, Not Just a Procedure! Jeffrey A Southard, MD Cardiology May 5, 2012 TAVR: It s a Career, Not Just a Procedure! Jeffrey A Southard, MD Cardiology May 5, 2012 Transcatheter Aortic Valve Replacement T- eam A- pproach to V- alve R- eplacement UCDMC Team Administration Cardiology

More information

Figure 2. Normal ECG tracing. Table 1.

Figure 2. Normal ECG tracing. Table 1. Figure 2. Normal ECG tracing that navigates through the left ventricle. Following these bundle branches the impulse finally passes to the terminal points called Purkinje fibers. These Purkinje fibers are

More information

INTERNAL MEDICINE SUBSPECIALTY CARDIOLOGY

INTERNAL MEDICINE SUBSPECIALTY CARDIOLOGY KALEIDA HEALTH Name: Date: INTERNAL MEDICINE SUBSPECIALTY CARDIOLOGY PLEASE NOTE: Please check the box for each requested. Do not use an arrow or line to make selections. We will return applications that

More information

Establishing a New Path Forward for Patients With Severe Symptomatic Aortic Stenosis THE PARTNER TRIAL CLINICAL RESULTS

Establishing a New Path Forward for Patients With Severe Symptomatic Aortic Stenosis THE PARTNER TRIAL CLINICAL RESULTS Establishing a New Path Forward for Patients With Severe Symptomatic Aortic Stenosis THE PARTNER TRIAL CLINICAL RESULTS E D W A R D S T R A N S C A T H E T E R H E A R T V A L V E P R O G R A M T h e Pa

More information

Hybrid Muscular VSD Closure in Small Weight Children

Hybrid Muscular VSD Closure in Small Weight Children Hybrid Muscular VSD Closure in Small Weight Children Shakeel A Qureshi, on behalf of: John P. Cheatham, MD George H. Dunlap Endowed Chair in Interventional Cardiology Director Cardiac Catheterization &

More information

Transcatheter Aortic Valve Replacement

Transcatheter Aortic Valve Replacement Transcatheter Aortic Valve Replacement Jesse Jorgensen, MD Medical Director, Cardiac Catheterization Laboratory Greenville Health System Greenville, South Carolina, USA January 30, 2016 Aortic Stenosis

More information

Masterclass III Advances in cardiac intervention. Percutaneous valvular intervention a novel approach

Masterclass III Advances in cardiac intervention. Percutaneous valvular intervention a novel approach Masterclass III Advances in cardiac intervention Percutaneous valvular intervention a novel approach Professor Roger Boyle CBE National Director for Heart Disease and Stroke London Medical therapy Medical

More information

Index. Note: Page numbers of article titles are in boldface type.

Index. Note: Page numbers of article titles are in boldface type. Index Note: Page numbers of article titles are in boldface type. A Ablation, radiofrequency, anesthetic considerations for, 479 489 Acute aortic syndrome, thoracic endovascular repair of, 457 462 aortic

More information

Girish M Nair, Seeger Shen, Pablo B Nery, Calum J Redpath, David H Birnie

Girish M Nair, Seeger Shen, Pablo B Nery, Calum J Redpath, David H Birnie 268 Case Report Cardiac Resynchronization Therapy in a Patient with Persistent Left Superior Vena Cava Draining into the Coronary Sinus and Absent Innominate Vein: A Case Report and Review of Literature

More information

Kadlec Regional Medical Center Cardiac Electrophysiology

Kadlec Regional Medical Center Cardiac Electrophysiology Definition of electrophysiology study and ablation Kadlec Regional Medical Center Cardiac Electrophysiology Electrophysiology Study and Ablation An electrophysiology, or EP, study is a test of the heart

More information

Rotation: Echocardiography: Transthoracic Echocardiography (TTE)

Rotation: Echocardiography: Transthoracic Echocardiography (TTE) Rotation: Echocardiography: Transthoracic Echocardiography (TTE) Rotation Format and Responsibilities: Fellows rotate in the echocardiography laboratory in each clinical year. Rotations during the first

More information

TAVR IN INTERMEDIATE-RISK PATIENTS

TAVR IN INTERMEDIATE-RISK PATIENTS TAVR IN INTERMEDIATE-RISK PATIENTS K. Lampropoulos MD, PhD, FESC, MEAPCI Interventional Cardiologist Evangelismos General Hospital The Burden of Valve Disease Prevalence Survival NATURAL HISTORY OF AS

More information

Transcatheter Aortic Valve Implantation (TAVI) - 5 important lessons learnt from HK experiences Michael KY Lee

Transcatheter Aortic Valve Implantation (TAVI) - 5 important lessons learnt from HK experiences Michael KY Lee Transcatheter Aortic Valve Implantation (TAVI) - 5 important lessons learnt from HK experiences Michael KY Lee Queen Elizabeth Hospital, Hong Kong President, HKSTENT APCASH 2013 SJ Park TAVI Summit 2013

More information

Echo Assessment Pre-TAVI

Echo Assessment Pre-TAVI Disclosure Statement of Financial Interest Within the past 12 months, I or my spouse/partner have had a financial Interest /arrangement or affiliation with the organization(s) listed below Echocardiographic

More information

Transvenous Pacemaker Procedures

Transvenous Pacemaker Procedures Cardiology: Pacemaker and Defibrillator Coding Presented By: Moderate Sedation 2017 99151 : under age 5, initial 15 minutes by MD performing intervention 99152: age 5 or older, initial 15 minutes by MD

More information

Trans Catheter Aortic Valve Replacement

Trans Catheter Aortic Valve Replacement Trans Catheter Aortic Valve Replacement Satish K Surabhi, MD,FACC,FSCAI Medical Director, Cardiac Cath Labs AnMed Health Heart and Vascular Care No financial conflict of interest related to this talk Will

More information

Valvular Intervention

Valvular Intervention Valvular Intervention Outline Introduction Aortic Stenosis Mitral Regurgitation Conclusion Calcific Aortic Stenosis Deformed Eccentric Calcified Nodular Rigid HOSTILE TARGET difficult to displace prone

More information

TAVR in Intermediate Risk Populations /Optimizing Systems for TAVR

TAVR in Intermediate Risk Populations /Optimizing Systems for TAVR TAVR in Intermediate Risk Populations /Optimizing Systems for TAVR Saibal Kar, MD, FACC, FAHA, FSCAI Professor of Medicine Director of Interventional Cardiac Research Smidt Heart Institute, Cedars-Sinai

More information

TAVI After PARTNER-2 : The Hamilton Approach

TAVI After PARTNER-2 : The Hamilton Approach TAVI After PARTNER-2 : The Hamilton Approach James L. Velianou MD FRCPC Interventional Cardiology Hamilton General Hospital St Catharines General Hospital Associate Professor of Medicine McMaster University

More information

Percutaneous Mechanical Circulatory Support Devices

Percutaneous Mechanical Circulatory Support Devices Percutaneous Mechanical Circulatory Support Devices Daniel Vazquez RN, RCIS Miami Cardiac & Vascular Institute FINANCIAL DISCLOSURES none CASE STUDY CASE STUDY 52 year old gentlemen Complaining of dyspnea

More information

Embolic Protection Devices for Transcatheter Aortic Valve Replacement

Embolic Protection Devices for Transcatheter Aortic Valve Replacement Embolic Protection Devices for Transcatheter Aortic Valve Replacement James M. McCabe, MD Medical Director, Cardiac Cath Lab University of Washington Seattle, WA Disclosures Proctoring and honoraria for

More information

TAVR SPRING 2017 The evolution of TAVR

TAVR SPRING 2017 The evolution of TAVR TAVR SPRING 2017 The evolution of TAVR Matthew Johnson, MD Disclosers None Evolution of the Balloon- Expandable Transcatheter Valves Cribier 2002 SAPIEN 2006 SAPIEN XT 2009 SAPIEN 3 2013 * Sheath compatibility

More information

National Imaging Associates, Inc. Clinical guidelines CARDIAC CATHETERIZATION -LEFT HEART CATHETERIZATION. Original Date: October 2015 Page 1 of 5

National Imaging Associates, Inc. Clinical guidelines CARDIAC CATHETERIZATION -LEFT HEART CATHETERIZATION. Original Date: October 2015 Page 1 of 5 National Imaging Associates, Inc. Clinical guidelines CARDIAC CATHETERIZATION -LEFT HEART CATHETERIZATION CPT Codes: 93451, 93452, 93453, 93454, 93455, 93456, 93457, 93458, 93459, 93460, 93461 LCD ID Number:

More information

TAVR-Update Andrzej Boguszewski MD, FACC, FSCAI Vice Chairman, Cardiology Mid-Michigan Health Associate Professor Michigan State University, Central

TAVR-Update Andrzej Boguszewski MD, FACC, FSCAI Vice Chairman, Cardiology Mid-Michigan Health Associate Professor Michigan State University, Central TAVR-Update Andrzej Boguszewski MD, FACC, FSCAI Vice Chairman, Cardiology Mid-Michigan Health Associate Professor Michigan State University, Central Michigan University 1 Disclosure Chiesi Pharma- Consultant

More information

TAVI complication. Possible aetiology and how to manage

TAVI complication. Possible aetiology and how to manage TAVI complication. Possible aetiology and how to manage Dr Sanjeevan Pasupati Waikato Hospital, Hamilton, New Zealand Operators: Dr Sanjeevan Pasupati, Mr Nand Kejriwal, Mr Adam Elgamel Valve Positioning

More information

Key Words: Balloon Venoplasty of Subclavian Vein, Cardiac Resynchronisation Therapy. Case report

Key Words: Balloon Venoplasty of Subclavian Vein, Cardiac Resynchronisation Therapy. Case report 221 Case Report Balloon Venoplasty of Subclavian Vein and Brachiocephalic Junction to Enable Left Ventricular Lead Placement for Cardiac Resynchronisation Therapy Thanh Trung Phan, Simon James, Andrew

More information

HOW IMPORTANT ARE THESE ECHO MEASUREMENTS ANYWAY?

HOW IMPORTANT ARE THESE ECHO MEASUREMENTS ANYWAY? HOW IMPORTANT ARE THESE ECHO MEASUREMENTS ANYWAY? John D. Carroll, MD Professor, Director of Interventional Cardiology and Co-Medical Director of the Cardiac and Vascular Center, University of Colorado

More information

TAVR for low-risk patients in 2017: not so fast.

TAVR for low-risk patients in 2017: not so fast. TAVR for low-risk patients in 2017: not so fast. Enrico Ferrari, MD, FETCS Cardiac Surgery Department Cardiocentro Ticino Foundation Lugano, Switzerland Conflicts of Interest Consultant and proctor for

More information

Mechanics of Cath Lab Support Devices

Mechanics of Cath Lab Support Devices Mechanics of Cath Lab Support Devices Issam D. Moussa, MD Chief Medical Officer First Coast Cardiovascular Institute, Jacksonville, FL Professor of Medicine, UCF, Orlando, FL None DISCLOSURE Percutaneous

More information

Percutaneous VSD closure

Percutaneous VSD closure Percutaneous VSD closure Gianfranco Butera San Donato Milanese - Italy Patients selection Pts having hemodynamically significant VSD Left ventricular enlargement (left ventricular overload),defined as

More information

The Adolescent and Adult Congenital Heart Disease Program

The Adolescent and Adult Congenital Heart Disease Program The Adolescent and Adult Congenital Heart Disease Program The Heart Center at Nationwide Children s Hospital & The Ohio State University D- Transposition of the Great Vessels D- transposition of the great

More information

New York Valves Patient focused evidence-based approach. New York City: 6 December Antonio Colombo

New York Valves Patient focused evidence-based approach. New York City: 6 December Antonio Colombo New York Valves 2018 Patient focused evidence-based approach New York City: 6 December 2018 Antonio Colombo Speaker 7 EMO GVM Centro Cuore Columbus Milan, Italy No conflicts to report Vascular complications

More information

Transcatheter aortic valve replacement (TAVR)

Transcatheter aortic valve replacement (TAVR) Building an Efficient TAVR Program BY SANDEEP M. PATEL, MD; J. BRANDON ELMORE, MD; EDWIN G. AVERY, MD; MARCO A. COSTA, MD, PhD; ALAN MARKOWITZ, MD; ANGELA DAVIS, RN; AND GUILHERME F. ATTIZZANI, MD; ON

More information

Indication, Timing, Assessment and Update on TAVI

Indication, Timing, Assessment and Update on TAVI Indication, Timing, Assessment and Update on TAVI Swedish Heart and Vascular Institute Ming Zhang MD PhD Interventional Cardiology Structure Heart Disease Conflict of Interest None Starr- Edwards Mechanical

More information

Mechanics of Cath Lab Support Devices

Mechanics of Cath Lab Support Devices Mechanics of Cath Lab Support Devices Issam D. Moussa, MD Professor of Medicine Mayo Clinic College of Medicine Chair, Division of Cardiovascular Diseases Mayo Clinic Jacksonville, Florida DISCLOSURE Presenter:

More information

Index. interventional.theclinics.com. Note: Page numbers of article titles are in boldface type.

Index. interventional.theclinics.com. Note: Page numbers of article titles are in boldface type. Index Note: Page numbers of article titles are in boldface type. A Ablation, of mitral leaflets, 80 Accucinch Annuloplasty system, for mitral regurgitation, 79, 94 95 Accutrak delivery system, for CoreValve

More information

Comments restricted to Sapien and Corevalve 9/12/2016. Disclosures: Core Lab contracts with Edwards Lifesciences, Middlepeak, Medtronic

Comments restricted to Sapien and Corevalve 9/12/2016. Disclosures: Core Lab contracts with Edwards Lifesciences, Middlepeak, Medtronic Para-ValvularRegurgitation post TAVR: Predict, Prevent, Quantitate, Manage Linda D. Gillam, MD, MPH, FACC, FASE Chair, Department of Cardiovascular Medicine Morristown Medical Center/Atlantic Health System

More information

Successful Percutaneous Closure of Mitral Bioprosthetic Paravalvular Leak Using Figulla ASD Occluder

Successful Percutaneous Closure of Mitral Bioprosthetic Paravalvular Leak Using Figulla ASD Occluder Hans R. Figulla, M.D., PhD ; Ali Hamadanchi, M.D. Medicine, Pneumology Universitity Hospital, Jena, Germany Successful Percutaneous Closure of Mitral Bioprosthetic Paravalvular Leak Using Figulla ASD Occluder

More information

Is TAVR Now Indicated in Even Low Risk Aortic Valve Disease Patients

Is TAVR Now Indicated in Even Low Risk Aortic Valve Disease Patients Is TAVR Now Indicated in Even Low Risk Aortic Valve Disease Patients Saibal Kar, MD, FACC, FAHA, FSCAI Director of Interventional Cardiac Research Cedars Sinai Heart Institute, Los Angeles, CA Potential

More information

UPMC University of Pittsburgh Medical Center. For Reference Only MEDICINE 2013

UPMC University of Pittsburgh Medical Center. For Reference Only MEDICINE 2013 Summary of Services and Availability (by location) Each location has sufficient space, equipment, staffing and financial resources in place or available in sufficient time as required to support each requested

More information

Percutaneous atrial septal defect closure with the Occlutech Figulla Flex ASD Occluder.

Percutaneous atrial septal defect closure with the Occlutech Figulla Flex ASD Occluder. Percutaneous atrial septal defect closure with the Occlutech Figulla Flex ASD Occluder. First case with a novel delivery system. Werner Budts, Md, PhD, FESC Congenital and Structural Cardiology University

More information

Successful Transfemoral Edwards Sapien Aortic. Valve Implantation in a Patient with Previous. Mitral Valve Replacement

Successful Transfemoral Edwards Sapien Aortic. Valve Implantation in a Patient with Previous. Mitral Valve Replacement Advanced Studies in Medical Sciences, Vol. 2, 2014, no. 1, 37-45 HIKARI Ltd, www.m-hikari.com http://dx.doi.org/10.12988/asms.2014.31213 Successful Transfemoral Edwards Sapien Aortic Valve Implantation

More information

Jay Simonson, MD, FACC, FHRS Medical Director, Cardiac Electrophysiology Park Nicollet Heart and Vascular Center

Jay Simonson, MD, FACC, FHRS Medical Director, Cardiac Electrophysiology Park Nicollet Heart and Vascular Center Jay Simonson, MD, FACC, FHRS Medical Director, Cardiac Electrophysiology Park Nicollet Heart and Vascular Center A-Fib Facts Yes, you may be able to blame your parents It is more of a nuisance than a

More information

Aortic Stenosis: Interventional Choice for a 70-year old- SAVR, TAVR or BAV? Interventional Choice for a 90-year old- SAVR, TAVR or BAV?

Aortic Stenosis: Interventional Choice for a 70-year old- SAVR, TAVR or BAV? Interventional Choice for a 90-year old- SAVR, TAVR or BAV? Aortic Stenosis: Interventional Choice for a 70-year old- SAVR, TAVR or BAV? Interventional Choice for a 90-year old- SAVR, TAVR or BAV? Samin K Sharma, MD, FACC, FSCAI Director Clinical & Interventional

More information

Antonio Colombo. Centro Cuore Columbus and S. Raffaele Scientific Institute, Milan, Italy. Miracor Symposium. Speaker: 15. Parigi: May 16-19, 2017

Antonio Colombo. Centro Cuore Columbus and S. Raffaele Scientific Institute, Milan, Italy. Miracor Symposium. Speaker: 15. Parigi: May 16-19, 2017 Parigi: May 16-19, 2017 Miracor Symposium Speaker: 15 Antonio Colombo Centro Cuore Columbus and S. Raffaele Scientific Institute, Milan, Italy Nothing to disclose PiCSO Impulse System Elective high risk

More information

Use of EKOS Catheter in the management of Venous Mr. Manoj Niverthi, Mr. Sarang Pujari, and Ms. Nupur Dandavate, The GTF Group

Use of EKOS Catheter in the management of Venous Mr. Manoj Niverthi, Mr. Sarang Pujari, and Ms. Nupur Dandavate, The GTF Group Use of EKOS Catheter in the management of Venous Thromboembolism @ Mr. Manoj Niverthi, Mr. Sarang Pujari, and Ms. Nupur Dandavate, The GTF Group Introduction Georgia Thrombosis Forum (GTF, www.gtfonline.net)

More information

Aortic Valve Stenosis and TAVR: Putting it all together.

Aortic Valve Stenosis and TAVR: Putting it all together. Aortic Valve Stenosis and TAVR: Putting it all together. Maria L. Held, MSN CNS Valve Clinic Coordinator at The Cleveland Clinic Alliance of Cardiovascular Professionals April 14 th, 2018 Brief Anatomy

More information

Drs. Rottman, Salloum, Campbell, Muldowney, Hong, Bagai, Kronenberg

Drs. Rottman, Salloum, Campbell, Muldowney, Hong, Bagai, Kronenberg Rotation: or: Faculty: Coronary Care Unit (CVICU) Dr. Jeff Rottman Drs. Rottman, Salloum, Campbell, Muldowney, Hong, Bagai, Kronenberg Duty Hours: Mon Fri, 7 AM to 7 PM, weekend call shared with consult

More information

For Personal Use. Copyright HMP 2013

For Personal Use. Copyright HMP 2013 Case Report J INVASIVE CARDIOL 2013;25(2):E42-E44 Percutaneous Closure of Iatrogenic Ventricular Septal Defect Following Surgical Aortic Valve Replacement Using Two Different Approaches Takashi Matsumoto,

More information

Cardiac Resynchronisation Therapy Patient Information

Cardiac Resynchronisation Therapy Patient Information Melbourne Heart Rhythm Cardiac Resynchronisation Therapy Patient Information Normal Heart Function The heart is a pump responsible for maintaining blood supply to the body. It has four chambers. The two

More information

Left Atrial Appendage Occlusion

Left Atrial Appendage Occlusion Left Atrial Appendage Occlusion A new strategy to prevent stroke in atrial fibrillation Ashok Talreja MD and Arijit Chanda MD VHVI symposium 24th February 2018 Outline of presentation 1. Risk of stroke

More information

Clinical Trial Coverage Analysis Workshop Practice Device Study

Clinical Trial Coverage Analysis Workshop Practice Device Study Clinical Trial Coverage Analysis Workshop Practice Device Study Aortic Valve Replacement in Extreme Risk Patients with Severe Aortic Stenosis Not Suitable for Standard Open Heart Surgery Replacement Protocol

More information

Cryptogenic Stroke: A logical approach to a common clinical problem

Cryptogenic Stroke: A logical approach to a common clinical problem Cryptogenic Stroke: A logical approach to a common clinical problem Alphonse M. Ambrosia, DO, FACC Interventional Cardiologist CardioVascular Associates of Mesa Mesa, Arizona Speakers Bureau Boston Scientific

More information

Percutaneous Transapical Access for Thoracic Endovascular Repair

Percutaneous Transapical Access for Thoracic Endovascular Repair Percutaneous Transapical Access for Thoracic Endovascular Repair Atman P. Shah MD FACC FSCAI Co-Director, Hans Hecht Cardiac Catheterization Laboratory Clinical Director, Section of Cardiology Associate

More information

22/06/2017. Oxford City. Transcatheter aortic valve replacement 2017 guidelines. 1. First time I have heard about it. 2.

22/06/2017. Oxford City. Transcatheter aortic valve replacement 2017 guidelines. 1. First time I have heard about it. 2. Oxford City Transcatheter aortic valve replacement 2017 guidelines Monday 19 th June Jim Newton Oxford Oxford University Hospitals NHS FT How familiar are you with TAVR? 1. First time I have heard about

More information